Clinical Trials Directory

Trials / Unknown

UnknownNCT04693975

Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases

Impact of Social Distancing During the COVID-19 Pandemic on Non-infected People With Chronic Respiratory Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
94 (estimated)
Sponsor
Universidade Estadual de Londrina · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Social distancing during the COVID-19 pandemic could lead to clinical and functional deterioration of people living with chronic respiratory diseases (CRD). As they are considered risk group for COVID-19, it is not recommended that they leave their house and have interaction with people outside. Thus, most of them have not been attend Pulmonary Rehabilitation sections since the beginning of pandemic, neither exercising outdoor, experiencing drastic restrictions in their activities of daily living. It is well known that low level of physical activity in daily life (PADL) in this population is related to poor prognosis, including higher chance of hospitalization due to exacerbation and mortality. Therefore, the aim of this study is to evaluate the short- and mid-term impact of the COVID-19 pandemic on the clinical, physical and functional conditions and the PADL level of people living with CRD (chronic obstructive pulmonary disease, asthma and interstitial lung diseases). Participants will be assessed during the social isolation period and they will be reassessed immediately after release from social isolation. Thus, the subjects will be followed-up during 12 months to record symptoms, functional status, quality of life, exacerbations and hospitalizations. The researchers' hypothesis is that those patients will present very low level of PADL in association to sedentarism, poor functional status, more symptoms of dyspnoea, anxiety and depression, poor sleep quality and, consequently, will present more episodes of acute exacerbation of the disease and more hospital admission during the study protocol.

Conditions

Timeline

Start date
2020-10-16
Primary completion
2022-10-01
Completion
2022-10-01
First posted
2021-01-05
Last updated
2021-01-05

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04693975. Inclusion in this directory is not an endorsement.